Oral Semaglutide for Weight Loss | New NEJM Study Explained episode artwork

EPISODE · Feb 11, 2026 · 45 MIN

Oral Semaglutide for Weight Loss | New NEJM Study Explained

from Endocrine Matters · host Dr. Arti Thangudu

👉 Come see me in clinic:https://www.sacomplete.com/💌 Sign up for my newsletter:https://www.sacomplete.com/complete-medicine-blog🎧 Listen to the Endocrine Matters podcast:https://www.sacomplete.com/podcast🎙️ Welcome to the Endocrine Matters podcast.This podcast episode is sponsored by Complete Medicine and HeyHealthy.Welcome back to Endocrine Matters. I’m your host, Dr. Arti Thangudu, board-certified endocrinologist, menopause society certified practitioner, and founder of Complete Medicine, where we care for high-achieving women living with obesity, prediabetes, diabetes, thyroid disease, and metabolic conditions.In today’s episode, we’re doing something a little different—we’re bringing you inside a real endocrinology journal club, but in a way that’s practical, relatable, and meaningful whether you’re a clinician, trainee, or someone living with obesity or metabolic disease.I’m joined by two incredible endocrinologists and colleagues, Dr. Vidhya Illuri and Dr. Munira Mehta, as we break down a major new study published in the New England Journal of Medicine on oral semaglutide for weight loss.Together, we discuss:How this randomized, placebo-controlled trial was designedWhy placebo and blinding matter in clinical researchWhat the results actually show about weight loss outcomesClinically significant weight loss and why even 5% mattersSide effects, tolerability, and real-world prescribing challengesOral vs injectable GLP-1 medicationsAccess, pricing, pharmacy barriers, and why knowledgeable prescribing mattersWhy obesity is a chronic metabolic disease—not a cosmetic issueThe importance of nutrition, muscle preservation, bone health, and long-term follow-upIf you’ve been hearing a lot about GLP-1 medications and wondering what’s real, what’s hype, and how this applies to everyday endocrine practice and patient safety, this episode is for you.Our goal is to help you understand the science, the nuance, and the ethics behind prescribing powerful metabolic medications—so patients can get safe, effective, and compassionate care.If you’d like support navigating weight loss medications, metabolic health, menopause, or complex endocrine care, we’d love to help you at Complete Medicine.📍 Learn more about becoming a patient:https://www.sacomplete.com/📲 Follow along on Instagram: @drartithanguduThank you so much for listening and for supporting Endocrine Matters.

Episode metadata supplied by the publisher feed · Published Feb 11, 2026

Embed this episode

NOW PLAYING

Oral Semaglutide for Weight Loss | New NEJM Study Explained

0:00 45:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Endocrine Matters?

This episode is 45 minutes long.

When was this Endocrine Matters episode published?

This episode was published on February 11, 2026.

Can I download this Endocrine Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!